$534.78
Price
$119.6B
Market Cap
18.9
P/E Ratio
16.1
Forward P/E
$28.34
EPS (TTM)
0.58%
Dividend Yield
$1.1B
Cash
$48.7B
Total Debt
224M
Shares Out
$295.00
$552.90
52-Week Range
Institutional Ownership of HCA HEALTHCARE INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Brave Warrior Advisors|Glenn Greenberg
|
3.9K | $2M | $168.54 | +187.06% |
Trading Activity for HCA HEALTHCARE INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| SELL | -26.3% | 1.4M | $588M | $393.62 | |
| BUY | +1.1% | 101.1K | $43M | $393.62 | |
| BUY | +9.1% | 75.2K | $32M | $393.62 | |
| 2025-Q2 | |||||
| BUY | +58.5% | 1.9M | $717M | $367.50 | |
| SELL | -12.4% | 100.0K | $38M | $367.50 | |
| BUY | +11.2% | 69.0K | $26M | $367.50 | |
| BUY | +104.0% | 3.9K | $2M | $367.50 | |
| 2025-Q1 | |||||
| BUY | +6.4% | 1.2M | $408M | $320.94 | |
| BUY | NEW | 114.2K | $39M | $320.94 | |
| BUY | +9.6% | 62.0K | $21M | $320.94 | |
| SELL | EXIT | — | — | $320.94 | |
| SELL | -43.0% | 1.9K | $664493 | $320.94 | |
| 2024-Q4 | |||||
| BUY | +59.0% | 1.1M | $333M | $348.75 | |
| BUY | +11.1% | 56.6K | $17M | $348.75 | |
| BUY | NEW | 15.0K | $5M | $348.75 | |
| 2024-Q3 | |||||
| BUY | +6.7% | 698.0K | $284M | $371.58 | |
| BUY | +45.1% | 50.9K | $21M | $371.58 | |
| SELL | -12.9% | 3.4K | $1M | $371.58 | |
| 2024-Q2 | |||||
| BUY | +23.6% | 654.2K | $210M | $325.13 | |
| BUY | +63.8% | 35.1K | $11M | $325.13 | |
| SELL | EXIT | — | — | $325.13 | |
| 2024-Q1 | |||||
| SELL | -27.0% | 529.4K | $177M | $309.42 | |
| SELL | EXIT | — | — | $309.42 | |
| BUY | +25.0% | 25.0K | $8M | $309.42 | |
| BUY | +51.6% | 21.4K | $7M | $309.42 | |
| 2023-Q4 | |||||
| BUY | NEW | 725.2K | $196M | $246.38 | |
| BUY | NEW | 117.2K | $32M | $246.38 | |
| BUY | NEW | 20.0K | $5M | $246.38 | |
| BUY | +75.7% | 14.1K | $4M | $246.38 | |
| BUY | +182.1% | 3.9K | $1M | $246.38 | |
| 2023-Q3 | |||||
| SELL | EXIT | — | — | $273.25 | |
| BUY | NEW | 8.1K | $2M | $273.25 | |
| 2023-Q2 | |||||
| SELL | -30.2% | 600.0K | $182M | $276.24 | |
| SELL | EXIT | — | — | $276.24 | |
| SELL | -96.5% | 1.4K | $416678 | $276.24 | |
| 2023-Q1 | |||||
| BUY | NEW | 860.0K | $227M | $254.38 | |
| SELL | -90.7% | 38.7K | $10M | $254.38 | |
| SELL | -21.9% | 142.5K | $38M | $254.38 | |
| 2022-Q4 | |||||
| SELL | -1.4% | 415.0K | $100M | $227.30 | |
| BUY | +143.3% | 182.5K | $44M | $227.30 | |
| 2022-Q3 | |||||
| BUY | +0.2% | 420.9K | $77M | $204.66 | |
| 2022-Q2 | |||||
| SELL | -32.5% | 420.2K | $71M | $211.18 | |
| BUY | NEW | 75.0K | $13M | $211.18 | |
| 2022-Q1 | |||||
| BUY | NEW | 622.8K | $156M | $251.99 | |
| 2021-Q4 | |||||
| SELL | EXIT | — | — | $244.38 | |
| 2021-Q3 | |||||
| SELL | -4.4% | 387.0K | $94M | $249.25 | |
| 2021-Q2 | |||||
| SELL | EXIT | — | — | $206.28 | |
| SELL | -57.4% | 405.0K | $84M | $206.28 | |
| 2021-Q1 | |||||
| SELL | -14.3% | 1.5M | $282M | $175.25 | |
| SELL | -5.0% | 950.0K | $179M | $175.25 | |
| 2020-Q4 | |||||
| BUY | NEW | 1.7M | $288M | $149.40 | |
| BUY | +7.0% | 1.0M | $164M | $149.40 | |
| 2020-Q3 | |||||
| SELL | EXIT | — | — | $130.27 | |
| SELL | -10.9% | 935.0K | $117M | $130.27 | |
| SELL | EXIT | — | — | $130.27 | |
| 2020-Q2 | |||||
| BUY | +20.5% | 1.7M | $162M | $105.17 | |
| BUY | +268.4% | 1.1M | $102M | $105.17 | |
| BUY | NEW | 1.0M | $97M | $105.17 | |
| 2020-Q1 | |||||
| BUY | NEW | 1.4M | $124M | $143.45 | |
| BUY | NEW | 285.0K | $26M | $143.45 | |
| 2018-Q2 | |||||
| SELL | EXIT | — | — | $102.19 | |
| 2018-Q1 | |||||
| SELL | -48.8% | 282.9K | $27M | $98.92 | |
Insider Trading for HCA HEALTHCARE INC
6 Months Insider Sentiment
Buy $0
Sell $3.5M
0
Buys
2
Sells
-3.5M
Net
3
Grants
Largest
$4.0M
Hazen
$3.1M
Mcalevey
$1.9M
Cuffe
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Samuel N Hazen | CEO | GRANT | 14.8K | — | — |
| Nov 05, 2025 | Mike A Marks | EVP and CFO | GRANT | 165 | — | — |
| Nov 05, 2025 | Michael R Mcalevey | EVP & Chief Legal & Admin Off. | SELL | 3.9K | $473.79 | $1.8M |
| Nov 03, 2025 | Mike A Marks | EVP and CFO | GRANT | 165 | — | — |
| Nov 03, 2025 | Michael R Mcalevey | EVP & Chief Legal & Admin Off. | EXERCISE | 13.2K | $236.61 | $3.1M |
| Oct 31, 2025 | Samuel N Hazen | CEO | EXERCISE | 58.0K | $69.58 | $4.0M |
| Sep 08, 2025 | Michael S. Cuffe | EVP and Chief Clinical Officer | SELL | 3.8K | $418.84 | $1.6M |
| Sep 04, 2025 | Michael S. Cuffe | EVP and Chief Clinical Officer | EXERCISE | 10.9K | $173.12 | $1.9M |